CPT Capital

CPT Capital
Description: Founded in 2017, CPT Capital is a London-based venture capital firm specializing in investments within the alternative protein and food technology sectors. As the venture arm of a leading private family office, CPT Capital partners with visionary companies using cutting-edge technologies to shape the future of protein and materials.
Contact:
Key People:
  • Harry Kalms,
  • Mélody Violton,
Portfolio:
Stage Focus: Pre-Seed, Seed, Series A, Series B
External Info: CPT Capital targets companies operating in sectors such as:Plant-Based Proteins: Derived from plant sources optimized for taste, texture, and nutrition to biomimic animal products. Biomass Fermentation: Utilizing fast-growing, non-animal origin cells (e.g., mycoprotein, algae) as functional proteins. Recombinant Proteins: Producing specific animal proteins (e.g., casein, whey) via precision fermentation or molecular farming. Cultivated Meat: Growing complete animal cells (e.g., muscle, fat) in nutrient-rich culture mediums. Enabling Technologies: Developing technologies and infrastructure to facilitate the transition away from traditional animal-based food systems. Operating with a collaborative and mission-driven approach, CPT Capital:Provides Long-Term Support: Investing from pre-seed stages through to sale or IPO, with a commitment to backing companies throughout their growth journey. Seeks Strategic Alignment: Focusing on companies with products that directly replace animal-derived products and possess strong technological or IP-protected elements. Maintains Global Perspective: Open to opportunities across the globe, with current exposure in the US, Israel, Europe, the UK, and Asia.
References:
Claim profile